BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9656775)

  • 1. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
    Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
    Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular immunotherapy in chronic myeloid leukemia].
    Fernández MN
    Sangre (Barc); 1998 Apr; 43(2):164-70. PubMed ID: 9656778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
    Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
    Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
    [No Abstract]   [Full Text] [Related]  

  • 5. Autografting for CML--overview and perspectives.
    Goldman JM
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S71-4. PubMed ID: 8769708
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects.
    Lion T
    Leukemia; 1996 May; 10(5):896-900; discussion 901-6. PubMed ID: 8656687
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelogenous leukemia--update and future directions.
    Kantarjian HM; Deisseroth A; Talpaz M
    Rev Invest Clin; 1994 Apr; Suppl():118-24. PubMed ID: 7886295
    [No Abstract]   [Full Text] [Related]  

  • 9. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B; Pasternak G; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic myeloid leukemia in the 21st century: biology and treatment].
    Chávez-González MA; Ayala-Sánchez M; Mayani H
    Rev Invest Clin; 2009; 61(3):221-32. PubMed ID: 19736811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karyotype and BCR studies after bone marrow transplantation for chronic myeloid leukaemia.
    Ruutu T; Peltomäki P; Volin L; Lindlöf M; Knuutila S
    Bone Marrow Transplant; 1991; 7 Suppl 2():20. PubMed ID: 1878697
    [No Abstract]   [Full Text] [Related]  

  • 12. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-alpha in chronic myeloid leukemia].
    Hehlmann R
    Fortschr Med; 1997 Mar; 115(9):30-4, 37-8. PubMed ID: 9206694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
    Petukhov VI; Strozha IL; Bondare DK
    Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous bone marrow transplantation in chronic myeloid leukaemia.
    Divya
    Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myeloid leukemia.
    Sawyers CL
    N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis.
    Santucci MA; Soligo D; Pileri S; Zuffa E; Testoni N; Tura S
    Leuk Lymphoma; 1993; 11 Suppl 1():113-8. PubMed ID: 8251886
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon treatment in chronic myeloid leukemia].
    Simonsson B
    Nord Med; 1992; 107(3):76-7, 79. PubMed ID: 1549456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon-alpha in chronic myeloid leukemia.
    Kumar L; Basade M; Gulati SC
    J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.